Algo version: 0.98b
Cizzle Biotechnology is listed at the LSE Exchange
Cizzle Biotechnology [CIZ.L]
LSE Sector: Healthcare Industry:Biotechnology

Is Cizzle Biotechnology stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Cizzle Biotechnology 10 years ago, but if you had invested on Friday 14th of May 2021 when the price was GBP9.38, you would have made a loss of GBP-7.88 per share or -84.00%

Yes, the average daily trading liquidity for Cizzle Biotechnology is GBP1.12 million. You should therefore be able to get in and out of your positions relatively fast.

Cizzle Biotechnology has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Cizzle Biotechnology to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.